BeStock  
Stocks › Biotechnology › ASND

Ascendis Pharma A/S ASND

US equityMarket cap rank #681Biotechnology
$227.46 −$0.37 (-0.16%)
Market open · Oct 1, 1:20 pm ET · After hours $227.83 0.00%
Open$228.03
Prev close$227.83
Day range$226.76 – $229.66
Volume408.7K
Market cap$14.97B
P/E (TTM)17.9
Dividend yield–

ASND Stock News

Headlines matching Ascendis Pharma A/S or the ASND ticker, most recent first.

  • Barclays Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Maintains Target Price $329Market news · 30 Sep 2026
  • Oppenheimer Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Raises Target Price to $312Market news · 3 Sep 2026
  • Morgan Stanley Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Maintains Target Price $273Market news · 28 Sep 2026
  • A Quick Look at Today's Ratings for Ascendis Pharma A/S(ASND.US), With a Forecast Between $273 to $344Market news · 2 Sep 2026
  • Wedbush Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Maintains Target Price $327Market news · 17 Sep 2026
  • A Quick Look at Today's Ratings for Ascendis Pharma A/S(ASND.US), With a Forecast Between $304 to $344Market news · 16 Sep 2026
  • Raymond James Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Raises Target Price to $287Market news · 15 Sep 2026
  • H.C. Wainwright Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Maintains Target Price $344Market news · 10 Sep 2026
  • Evercore Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Maintains Target Price $329Market news · 8 Aug 2026
  • Cantor Fitzgerald Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Maintains Target Price $300Market news · 8 Aug 2026
  • Barclays Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Maintains Target Price $345Market news · 7 Aug 2026
  • H.C. Wainwright Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Cuts Target Price to $344Market news · 31 Aug 2026
  • Morgan Stanley Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Maintains Target Price $275Market news · 31 Aug 2026
  • H.C. Wainwright Initiates Ascendis Pharma A/S(ASND.US) With Buy Rating, Announces Target Price $345Market news · 27 Aug 2026
  • J.P. Morgan Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Announces Target Price $300Market news · 20 Aug 2026

Discussion

No comments yet — be the first to weigh in on ASND.

Leave a comment

Scroll to Top